BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28761139)

  • 1. Biosynthesis of brain cytoplasmic 200 RNA.
    Kim Y; Lee J; Shin H; Jang S; Kim SC; Lee Y
    Sci Rep; 2017 Jul; 7(1):6884. PubMed ID: 28761139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation.
    Booy EP; McRae EK; Koul A; Lin F; McKenna SA
    Mol Cancer; 2017 Jun; 16(1):109. PubMed ID: 28651607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of BC200 RNA expression reduces cell migration and invasion by destabilizing mRNA for calcium-binding protein S100A11.
    Shin H; Lee J; Kim Y; Jang S; Lee Y; Kim S; Lee Y
    RNA Biol; 2017 Oct; 14(10):1418-1430. PubMed ID: 28277927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
    Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
    Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous Sequences of Brain Cytoplasmic 200 RNA Formed by Multiple Adenine Nucleotide Insertions.
    Shin H; Lee J; Kim Y; Jang S; Kim M; Lee Y
    Mol Cells; 2019 Jun; 42(6):495-500. PubMed ID: 31250622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Helicase Associated with AU-rich Element (RHAU/DHX36) Interacts with the 3'-Tail of the Long Non-coding RNA BC200 (BCYRN1).
    Booy EP; McRae EK; Howard R; Deo SR; Ariyo EO; Dzananovic E; Meier M; Stetefeld J; McKenna SA
    J Biol Chem; 2016 Mar; 291(10):5355-72. PubMed ID: 26740632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the BC200 ribonucleoprotein reveals a reciprocal regulatory function with CSDE1/UNR.
    Booy EP; McRae EK; Ezzati P; Choi T; Gussakovsky D; McKenna SA
    Nucleic Acids Res; 2018 Nov; 46(21):11575-11591. PubMed ID: 30247708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2.
    Jang S; Shin H; Lee J; Kim Y; Bak G; Lee Y
    FEBS Lett; 2017 Jan; 591(2):393-405. PubMed ID: 28027391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory BC200 RNA in peripheral blood of patients with invasive breast cancer.
    Iacoangeli A; Adzovic L; Chen EQ; Latif Cattie R; Soff GA; Tiedge H
    J Investig Med; 2018 Oct; 66(7):1055-1063. PubMed ID: 29967012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the cellular location of brain cytoplasmic 200 RNA using an RNA-recognizing antibody.
    Shin H; Lee J; Kim Y; Jang S; Ohn T; Lee Y
    BMB Rep; 2017 Jun; 50(6):318-322. PubMed ID: 28042783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells.
    Booy EP; Gussakovsky D; Choi T; McKenna SA
    J Biol Chem; 2021; 296():100036. PubMed ID: 33410401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of RNA motifs essential for BC200 RNA-mediated translational regulation.
    Jang S; Shin H; Lee Y
    BMB Rep; 2020 Feb; 53(2):94-99. PubMed ID: 31234958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The double-edged sword of long non-coding RNA: The role of human brain-specific BC200 RNA in translational control, neurodegenerative diseases, and cancer.
    Sosińska P; Mikuła-Pietrasik J; Książek K
    Mutat Res Rev Mutat Res; 2015; 766():58-67. PubMed ID: 26596549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two primate-specific small non-protein-coding RNAs in transgenic mice: neuronal expression, subcellular localization and binding partners.
    Khanam T; Rozhdestvensky TS; Bundman M; Galiveti CR; Handel S; Sukonina V; Jordan U; Brosius J; Skryabin BV
    Nucleic Acids Res; 2007; 35(2):529-39. PubMed ID: 17175535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone negatively regulates tumorigenesis through suppression of BC200.
    Lin YH; Wu MH; Huang YH; Yeh CT; Chi HC; Tsai CY; Chuang WY; Yu CJ; Chung IH; Chen CY; Lin KH
    Endocr Relat Cancer; 2018 Dec; 25(12):967-979. PubMed ID: 30400024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.
    Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D
    BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new core promoter element XCPE1 (X Core Promoter Element 1) directs activator-, mediator-, and TATA-binding protein-dependent but TFIID-independent RNA polymerase II transcription from TATA-less promoters.
    Tokusumi Y; Ma Y; Song X; Jacobson RH; Takada S
    Mol Cell Biol; 2007 Mar; 27(5):1844-58. PubMed ID: 17210644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA recognition by a human antibody against brain cytoplasmic 200 RNA.
    Jung E; Lee J; Hong HJ; Park I; Lee Y
    RNA; 2014 Jun; 20(6):805-14. PubMed ID: 24759090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the biological affection of long noncoding RNA BC200 in Alzheimer's disease.
    Li H; Zheng L; Jiang A; Mo Y; Gong Q
    Neuroreport; 2018 Sep; 29(13):1061-1067. PubMed ID: 29979260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of secondary and tertiary structures of human BC200 RNA (BCYRN1) based on experimental and bioinformatic cross-validation.
    Sosińska-Zawierucha P; Zawierucha P; Bręborowicz A; Barciszewski J
    Biochem J; 2018 Sep; 475(17):2727-2748. PubMed ID: 30072491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.